Pentwater Capital Management LP Moderna, Inc. Transaction History

Pentwater Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $389,730 - $704,940	-3,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $54,590 - $92,990	-500 Reduced 14.29%	3,000 $393,000
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $986,099 - $2.55 Million	-15,000 Reduced 81.08%	3,500 $366,000
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $543,400 - $948,500	-10,000 Reduced 35.09%	18,500 $1.31 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $296,700 - $800,000	10,000 Added 54.05%	28,500 $1.83 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $293,370 - $521,070	-16,500 Reduced 47.14%	18,500 $554,000
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $250,740 - $383,040	18,000 Added 105.88%	35,000 $685,000
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $208,420 - $307,190	17,000 New	17,000 $271,000
Q2 2019 Aug 14, 2019	SELL	$13.7 - $28.34 $137,000 - $283,400	-10,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$14.45 - $23.7 $144,500 - $237,000	-10,000 Reduced 50.0%	10,000 $204,000
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $270,400 - $376,000	20,000 New	20,000 $305,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.